Date Filed | Type | Description |
02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2022 |
SC 13G/A
| MILLER RICHARD A MD reports a 5.4% stake in Corvus Pharmaceuticals, Inc. |
02/12/2021 |
SC 13G/A
| MILLER RICHARD A MD reports a 7.5% stake in Corvus Pharmaceuticals, Inc. |
02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2018 |
SC 13G/A
| MILLER RICHARD A MD reports a 6.1% stake in Corvus Pharmaceuticals, Inc. |
02/10/2017 |
SC 13G/A
| Corvus Pharmaceuticals, Inc. reports a 5.2% stake in Corvus Pharmaceuticals, Inc. |
04/08/2016 |
SC 13G
| Corvus Pharmaceuticals, Inc. reports a 5.2% stake in Corvus Pharmaceuticals, Inc. |
02/13/2007 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
01/30/2006 |
SC 13G
| MILLER RICHARD A MD reports a 5.3% stake in PHARMACYCLICS, INC. |
02/14/2005 |
SC 13G
| MILLER RICHARD A MD reports a 5.1% stake in PHARMACYCLICS, INC. |
02/17/1998 |
SC 13G/A
| MILLER RICHARD A MD reports a 2.7% stake in PHARMACYCLICS, INC. |
02/10/1997 |
SC 13G/A
| MILLER RICHARD A MD reports a 3% stake in PHARMACYCLICS, INC. |